Hematology/Oncology News

Nancy Lin, MD, from the department of medical oncology at Dana-Farber Cancer Institute, discussed exciting OS data from the KEYNOTE-522 study presented at ESMO Congress.

Trastuzumab deruxtecan showed substantial and durable overall and intracranial clinical activity in patients with HER2-positive metastatic breast cancer, according to results from the DESTINYBreast-12 trial presented at ESMO Congress.

A common question we receive every 4 years is: How will the election impact my investments?

Skin cancer is the most prevalent cancer in the United States, with an estimated 97,610 new cases of invasive melanoma, 89,070 cases of in situ melanoma and about 7,990 deaths from the disease in 2023.

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2024 World Conference on Lung Cancer, as well as Healio’s top headlines from the meeting.

The timing with which patients with newly diagnosed multiple myeloma began treatment with oral antimyeloma medications varied greatly by age and race, according to retrospective study results.

Nearly 80% of individuals clinically diagnosed with stage I pancreatic ductal adenocarcinoma and close to 30% diagnosed with stage II disease got upstaged after surgery, according to retrospective study results.

Nearly two-thirds of patients with excessive alcohol use and a high fibrosis-4 index were not referred for liver-related care, with fewer referrals among those with mental health disorders or alcohol-related mental health hospitalizations.

Researchers have developed an AI model capable of using an inexpensive, easy-to-obtain chromatin image to determine the stage of ductal carcinoma.

CHICAGO — “Lift as you climb” in medicine and take the time to build relationships, according to Kimberly Manning, MD, FACP, FAAP.